文献速递临床试验与 GCP

急性中毒昏迷患者无创气道管理效果:一项随机临床试验

Effect of Noninvasive Airway Management of Comatose Patients With Acute Poisoning: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2023-01-01

这项在法国20个急诊科和1个ICU开展的多中心随机试验纳入225例格拉斯哥昏迷评分低于9分的疑似急性中毒昏迷患者,比较保守气道策略(不插管)与常规实践。干预组插管比例16%、对照组58%,住院期间无死亡。干预组主要复合终点(住院死亡、ICU住院时长、总住院时长)显示临床获益,胜率比1.85(95%CI 1.33至2.58),不良事件比例更低(6% vs 14.7%)。

要点

  • 疑似急性中毒昏迷且GCS<9分患者中,不插管的保守气道策略插管比例16%,常规实践为58%。
  • 干预组主要复合终点胜率比1.85(95%CI 1.33至2.58),显示临床获益。
  • 干预组任何不良事件比例6% vs 对照组14.7%,绝对风险差-8.6%(95%CI -16.6%至-0.7%)。

核心结论

  • 在疑似急性中毒的昏迷患者中,不插管的保守策略与住院死亡、ICU住院时长和总住院时长复合终点的更大临床获益相关。

研究设计与样本

  • 多中心随机试验,在法国20个急诊科和1个ICU开展,纳入疑似急性中毒且GCS<9分的昏迷患者,2021年5月16日至2023年4月12日入组,随访至2023年5月12日。
  • 共纳入225例患者(平均年龄33岁,女性38%),干预组116例、对照组109例。

主要发现

  • 干预组与对照组插管比例分别为16%和58%,住院期间无患者死亡。
  • 主要复合终点干预组胜率比1.85(95%CI 1.33至2.58)。
  • 干预组任何不良事件比例6% vs 对照组14.7%,绝对风险差-8.6%(95%CI -16.6%至-0.7%)。
  • 肺炎分别发生于干预组8例(6.9%)和对照组16例(14.7%),绝对风险差-7.8%(95%CI -15.9%至0.3%)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Tracheal intubation is recommended for coma patients and those with severe brain injury, but its use in patients with decreased levels of consciousness from acute poisoning is uncertain. OBJECTIVE: To determine the effect of intubation withholding vs routine practice on clinical outcomes of comatose patients with acute poisoning and a Glasgow Coma Scale score less than 9. DESIGN, SETTING, AND PARTICIPANTS: This was a multicenter, randomized trial conducted in 20 emergency departments and 1 intensive care unit (ICU) that included comatose patients with suspected acute poisoning and a Glasgow Coma Scale score less than 9 in France between May 16, 2021, and April 12, 2023, and followed up until May 12, 2023. INTERVENTION: Patients were randomized to undergo conservative airway strategy of intubation withholding vs routine practice. MAIN OUTCOMES AND MEASURES: The primary outcome was a hierarchical composite end point of in-hospital death, length of ICU stay, and length of hospital stay. Key secondary outcomes included adverse events resulting from intubation as well as pneumonia within 48 hours. RESULTS: Among the 225 included patients (mean age, 33 years; 38% female), 116 were in the intervention group and 109 in the control group, with respective proportions of intubations of 16% and 58%. No patients died during the in-hospital stay. There was a significant clinical benefit for the primary end point in the intervention group, with a win ratio of 1.85 (95% CI, 1.33 to 2.58). In the intervention group, there was a lower proportion with any adverse event (6% vs 14.7%; absolute risk difference, 8.6% [95% CI, -16.6% to -0.7%]) compared with the control group, and pneumonia occurred in 8 (6.9%) and 16 (14.7%) patients, respectively (absolute risk difference, -7.8% [95% CI, -15.9% to 0.3%]). CONCLUSIONS AND RELEVANCE: Among comatose patients with suspected acute poisoning, a conservative strategy of withholding intubation was associated with a greater clinical benefit for the composite end point of in-hospital death, length of ICU stay, and length of hospital stay. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04653597.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Freund Y, Viglino D, Cachanado M, et al. Effect of Noninvasive Airway Management of Comatose Patients With Acute Poisoning: A Randomized Clinical Trial. JAMA. 2023. PMID: 38019968. doi:10.1001/jama.2023.24391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。